Evidence map›Paper›PMID 38821935›Full record

ArticleBlood cancer journal2024

Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.

Sheren Younes, Ajay Subramanian, Anum Khan, Shuchun Zhao, Michael Binkley, Yasodha Natkunam

Abstract read
In one paragraph

Article in Blood cancer journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sheren YounesDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Ajay SubramanianRadiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0001-7892-886X
Anum KhanCell Sciences Imaging Facility, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Shuchun ZhaoDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Michael BinkleyRadiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Yasodha NatkunamDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA. yaso@stanford.edu.ORCID 0000-0002-9816-1018

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma with sparse tumor B-cells and a favorable prognosis. Variant growth patterns of NLPHL, however, often show advanced stage, progression to T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) and a worse prognosis. We studied the tumor microenvironment (TME) of NLPHL and THRLBCL using highplex imaging and spatial profiling at the single cell level. Our findings show distinct differences in TME composition and spatial configuration that differ among typical and variant NLPHL and THRLBCL. Typical NLPHL show abundant helper T-cell subsets, while THRLBCL show abundant cytotoxic T-cells and macrophages. Tumor B-cell size and content is lowest in typical NLPHL, followed by variant NLPHL, and highest in THRLBCL, whereas an opposite trend characterized TME B-cells. CD4/CD8 double-positive T-cells are seen in all NLPHL but not in the majority of THRLBCL and are spatially distant from LP-cells and TFH-rosettes. The differences in macrophage/monocyte content in distinguishing NLPHL pattern E from THRLBCL is further corroborated in independent cohorts of cases. Our results validate the current approach to classification and in addition provide novel insights that could be leveraged to refine clinical management for patients with this spectrum of lymphomas.

Indexed as

Hodgkin DiseaseLymphoma, Large B-Cell, DiffuseTumor MicroenvironmentAdultFemaleHistiocytesHumansMaleMiddle AgedT-Lymphocytes

Identifiers

PMID38821935
PMCPMC11143196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.